Airgain, Inc.
Airgain, Inc. (AIRG) Financial Performance & Income Statement Overview
Analyze Airgain, Inc. (AIRG) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Airgain, Inc. (AIRG) Income Statement & Financial Overview
Review Airgain, Inc. AIRG income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $12.01M | $15.08M | $16.10M | $15.18M |
| Cost of Revenue | $6.85M | $8.72M | $9.39M | $9.04M |
| Gross Profit | $5.16M | $6.36M | $6.71M | $6.15M |
| Gross Profit Ratio | $0.43 | $0.42 | $0.42 | $0.40 |
| R&D Expenses | $2.50M | $2.77M | $2.85M | $3.12M |
| SG&A Expenses | $5.76M | $5.57M | $5.67M | $5.54M |
| Operating Expenses | $8.26M | $8.34M | $8.53M | $8.65M |
| Total Costs & Expenses | $15.11M | $17.06M | $17.91M | $17.69M |
| Interest Income | $221000.00 | $33000.00 | $29000.00 | $27000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $919000.00 | $926000.00 | $883000.00 | $800000.00 |
| EBITDA | -$2.18M | -$1.05M | -$931000.00 | -$1.68M |
| EBITDA Ratio | -$0.18 | -$0.07 | -$0.06 | -$0.11 |
| Operating Income | -$3.10M | -$1.98M | -$1.81M | -$2.50M |
| Operating Income Ratio | -$0.26 | -$0.13 | -$0.11 | -$0.16 |
| Other Income/Expenses (Net) | $1.57M | $10000.00 | $18000.00 | $26000.00 |
| Income Before Tax | -$1.52M | -$1.97M | -$1.80M | -$2.48M |
| Income Before Tax Ratio | -$0.13 | -$0.13 | -$0.11 | -$0.16 |
| Income Tax Expense | $24000.00 | -$7000.00 | -$39000.00 | $34000.00 |
| Net Income | -$1.55M | -$1.96M | -$1.76M | -$2.51M |
| Net Income Ratio | -$0.13 | -$0.13 | -$0.11 | -$0.17 |
| EPS | -$0.13 | -$0.17 | -$0.16 | -$0.23 |
| Diluted EPS | -$0.13 | -$0.17 | -$0.16 | -$0.23 |
| Weighted Avg Shares Outstanding | $11.58M | $11.42M | $11.31M | $10.94M |
| Weighted Avg Shares Outstanding (Diluted) | $11.58M | $11.42M | $11.31M | $10.94M |
Over the past four quarters, Airgain, Inc. demonstrated steady revenue growth, increasing from $15.18M in Q2 2024 to $12.01M in Q1 2025. Operating income reached -$3.10M in Q1 2025, maintaining a consistent -26% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$2.18M, reflecting operational efficiency. Net income rose to -$1.55M, with EPS at -$0.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan